Self-monitoring of blood glucose (SMBG) enables those with diabetes to modify their behavior, adjust their medicine and understand their disease to better manage it, according to a recent study, published by SAGE in The Diabetes Educator. The research looked at "paired testing," a self-monitored testing both before and after specific events, to evaluate whether it could assist the patient in making better health and food choice decisions over time.
In the study, sponsored by Roche Diagnostics through an unrestricted educational grant, healthcare professionals from various medical specialties collaborated to review current research regarding the value and utility of SMBG and formulate professional opinions regarding its use. With the goal of encouraging patients' active involvement in the control of their own disease, instead of just blindly following the edicts of their healthcare providers, researchers found that paired testing can be helpful to:
"Although the utility of SMBG in non-insulin-treated Type 2 diabetes remains controversial," write the authors in the article, "a recent report from the International Diabetes Federation recommends SMBG use in this population if it is used to educate/motivate individuals and/or monitor and adjust therapy. Healthcare providers must develop strategies to utilize SMBG in ways that address these criteria."
The Diabetes Educator article, "Effective Use of Paired Testing in Type 2 Diabetes: Practical Applications in Clinical Practice," written by: Christopher G. Parkin, MS, Deborah Hinnen, ARNP, BC-ADM, CDE, FAAN, R. Keith Campbell, RPh, MBA, FASHP, CDE, Patricia Geil, MS, RD, FADA, CDE, David L. Tetrick, MD, and William H. Polonsky, PhD.
Materials provided by SAGE Publications. Note: Content may be edited for style and length.
Cite This Page: